Provided by Tiger Trade Technology Pte. Ltd.

Treace Medical Concepts, Inc.

4.81
+0.440010.07%
Pre-market: 4.51-0.3000-6.24%04:06 EDT
Volume:595.11K
Turnover:2.84M
Market Cap:312.82M
PE:-5.19
High:5.01
Open:4.70
Low:4.58
Close:4.37
52wk High:7.65
52wk Low:1.17
Shares:65.03M
Float Shares:46.95M
Volume Ratio:1.95
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9262
EPS(LYR):-0.9326
ROE:-71.99%
ROA:-17.33%
PB:4.62
PE(LYR):-5.16

Loading ...

Apr 26, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 11, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 08, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 07, 2023

Major Issues Report

8-K - Current report
Feb 23, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Major Issues Report

8-K - Current report
Feb 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2022

Major Issues Report

8-K - Current report
Sep 28, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2022

Major Issues Report

8-K - Current report
May 23, 2022

Major Issues Report

8-K - Current report
May 06, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]